Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Dillon

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
The FEBS Journal|April 28, 2006
The calcium-binding domain of the stress protein SEP53 is required for survival in response to deoxycholic acid-mediated injuryJoanne Darragh, Mairi Hunter, Elizabeth Pohler, et al.
The Lancet. Gastroenterology & Hepatology|May 7, 2022
Community pathways for the early detection and risk stratification of chronic liver disease: a narrative systematic reviewKushala W M Abeysekera, Iain Macpherson, Kate Glyn-Owen, et al.
Addiction (Abingdon, England)|February 22, 2023
Improved health-related quality of life after hepatitis C viraemic clearance among people who inject drugs may not be durableScott A McDonald, Gareth Myring, Norah E Palmateer, et al.
Addiction (Abingdon, England)|April 2, 2009
Association of self-reported alcohol use and hospitalization for an alcohol-related cause in Scotland: a record-linkage study of 23,183 individualsScott A McDonald, Sharon J Hutchinson, Sheila M Bird, et al.
AIDS Research and Therapy|April 26, 2026
Seroprevalence and viremia of hepatitis C virus among HIV-infected patients on ART with unsuppressed HIV viral load in EthiopiaDesta Ayana, Gadissa Gutema, Atsbeha Gebreegziabxier, et al.
BMJ Open|September 2, 2020
<u>R</u>eaching m<u>E</u>thadone users <u>A</u>ttending <u>C</u>ommunity p<u>H</u>armacies with HCV: an international cluster randomised controlled trial protocol (REACH HCV)Christopher Byrne, Andrew Radley, Sarah Karen Inglis, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 8, 2014
Health state utilities associated with attributes of treatments for hepatitis CLouis S Matza, Sandhya J Sapra, John F Dillon, et al.
Trials|November 1, 2025
Lessons learned from two multicentre randomised controlled trials undertaken in pharmacies in community settings: a retrospective project management analysisChristopher J Byrne, Sarah K Inglis, Andrew Radley, et al.
Journal of Viral Hepatitis|May 18, 2021
Uptake of interferon-free DAA therapy among HCV-infected decompensated cirrhosis patients and evidence for decreased mortalityScott A McDonald, Stephen T Barclay, Hamish A Innes, et al.
Free Radical Biology & Medicine|November 17, 2009
Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitisSudhir Chowdhry, Maiiada H Nazmy, Paul J Meakin, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
The FEBS Journal|April 28, 2006
The calcium-binding domain of the stress protein SEP53 is required for survival in response to deoxycholic acid-mediated injuryJoanne Darragh, Mairi Hunter, Elizabeth Pohler, et al.
The Lancet. Gastroenterology & Hepatology|May 7, 2022
Community pathways for the early detection and risk stratification of chronic liver disease: a narrative systematic reviewKushala W M Abeysekera, Iain Macpherson, Kate Glyn-Owen, et al.
Addiction (Abingdon, England)|February 22, 2023
Improved health-related quality of life after hepatitis C viraemic clearance among people who inject drugs may not be durableScott A McDonald, Gareth Myring, Norah E Palmateer, et al.
Addiction (Abingdon, England)|April 2, 2009
Association of self-reported alcohol use and hospitalization for an alcohol-related cause in Scotland: a record-linkage study of 23,183 individualsScott A McDonald, Sharon J Hutchinson, Sheila M Bird, et al.
AIDS Research and Therapy|April 26, 2026
Seroprevalence and viremia of hepatitis C virus among HIV-infected patients on ART with unsuppressed HIV viral load in EthiopiaDesta Ayana, Gadissa Gutema, Atsbeha Gebreegziabxier, et al.
BMJ Open|September 2, 2020
<u>R</u>eaching m<u>E</u>thadone users <u>A</u>ttending <u>C</u>ommunity p<u>H</u>armacies with HCV: an international cluster randomised controlled trial protocol (REACH HCV)Christopher Byrne, Andrew Radley, Sarah Karen Inglis, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 8, 2014
Health state utilities associated with attributes of treatments for hepatitis CLouis S Matza, Sandhya J Sapra, John F Dillon, et al.
Trials|November 1, 2025
Lessons learned from two multicentre randomised controlled trials undertaken in pharmacies in community settings: a retrospective project management analysisChristopher J Byrne, Sarah K Inglis, Andrew Radley, et al.
Journal of Viral Hepatitis|May 18, 2021
Uptake of interferon-free DAA therapy among HCV-infected decompensated cirrhosis patients and evidence for decreased mortalityScott A McDonald, Stephen T Barclay, Hamish A Innes, et al.
Free Radical Biology & Medicine|November 17, 2009
Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitisSudhir Chowdhry, Maiiada H Nazmy, Paul J Meakin, et al.
Pageof 18